[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations",
    "summary": "Regeneron Pharmaceuticals ( NASDAQ:REGN ) Second Quarter 2025 Results Key Financial Results Revenue: US$3.68b (up 3.6...",
    "url": "https://finnhub.io/api/news?id=a0a770758d7fc261e1995fa81345a39998e063b88800342ff9e8f3e1bdc46c90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754226982,
      "headline": "Regeneron Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations",
      "id": 136195611,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals ( NASDAQ:REGN ) Second Quarter 2025 Results Key Financial Results Revenue: US$3.68b (up 3.6...",
      "url": "https://finnhub.io/api/news?id=a0a770758d7fc261e1995fa81345a39998e063b88800342ff9e8f3e1bdc46c90"
    }
  },
  {
    "ts": null,
    "headline": "2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts",
    "summary": "These biotech businesses look compelling for very different reasons.",
    "url": "https://finnhub.io/api/news?id=b3d7264747e80176558e6d5291cb00a536bf03d60f70414cc2b2ce38002a30c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754215200,
      "headline": "2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts",
      "id": 136195612,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "These biotech businesses look compelling for very different reasons.",
      "url": "https://finnhub.io/api/news?id=b3d7264747e80176558e6d5291cb00a536bf03d60f70414cc2b2ce38002a30c2"
    }
  }
]